Global Non-Hodgkin Lymphoma Therapeutics Market Size, Status and Forecast 2018-2025
- QYR2792336
- 95 Pages
- October 2018
- Medical Devices
Factors such as demand for innovative drugs and novel technologies, FDA's approval for chronic lymphocytic leukemia therapy drugs, introduction of promising drugs such as novel small molecule inhibitors and next-generation monoclonal antibodies, and increase in prevalence of NHL drives the market growth.
However, high cost of the vaccines used in NHL therapy and side-effects associated with them restrain the market growth.
Moreover, introduction of newer biologics in the NHL market, patent expiry of standard drugs in untapped market provide numerous opportunities regarding healthcare in near future.
In 2017, the global Non-Hodgkin Lymphoma Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.
This report focuses on the global Non-Hodgkin Lymphoma Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Non-Hodgkin Lymphoma Therapeutics development in United States, Europe and China.
The key players covered in this study
Bristol Myers Squibb
Celgene
Eli Lilly
F. Hoffman La-Roche
GlaxoSmithKline
Accredo Health Group
Baxter International
Bayer
Cephalon
Eisai Pharmaceuticals
Market segment by Type, the product can be split into
Chemotherapy
Targeted Therapy
Market segment by Application, split into
Clinical Research
Treatment
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Non-Hodgkin Lymphoma Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Non-Hodgkin Lymphoma Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Non-Hodgkin Lymphoma Therapeutics are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Non-Hodgkin Lymphoma Therapeutics Market Size Growth Rate by Type (2013-2025)
1.4.2 Chemotherapy
1.4.3 Targeted Therapy
1.5 Market by Application
1.5.1 Global Non-Hodgkin Lymphoma Therapeutics Market Share by Application (2013-2025)
1.5.2 Clinical Research
1.5.3 Treatment
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Non-Hodgkin Lymphoma Therapeutics Market Size
2.2 Non-Hodgkin Lymphoma Therapeutics Growth Trends by Regions
2.2.1 Non-Hodgkin Lymphoma Therapeutics Market Size by Regions (2013-2025)
2.2.2 Non-Hodgkin Lymphoma Therapeutics Market Share by Regions (2013-2018)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Non-Hodgkin Lymphoma Therapeutics Market Size by Manufacturers
3.1.1 Global Non-Hodgkin Lymphoma Therapeutics Revenue by Manufacturers (2013-2018)
3.1.2 Global Non-Hodgkin Lymphoma Therapeutics Revenue Market Share by Manufacturers (2013-2018)
3.1.3 Global Non-Hodgkin Lymphoma Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Non-Hodgkin Lymphoma Therapeutics Key Players Head office and Area Served
3.3 Key Players Non-Hodgkin Lymphoma Therapeutics Product/Solution/Service
3.4 Date of Enter into Non-Hodgkin Lymphoma Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Non-Hodgkin Lymphoma Therapeutics Market Size by Type (2013-2018)
4.2 Global Non-Hodgkin Lymphoma Therapeutics Market Size by Application (2013-2018)
5 United States
5.1 United States Non-Hodgkin Lymphoma Therapeutics Market Size (2013-2018)
5.2 Non-Hodgkin Lymphoma Therapeutics Key Players in United States
5.3 United States Non-Hodgkin Lymphoma Therapeutics Market Size by Type
5.4 United States Non-Hodgkin Lymphoma Therapeutics Market Size by Application
6 Europe
6.1 Europe Non-Hodgkin Lymphoma Therapeutics Market Size (2013-2018)
6.2 Non-Hodgkin Lymphoma Therapeutics Key Players in Europe
6.3 Europe Non-Hodgkin Lymphoma Therapeutics Market Size by Type
6.4 Europe Non-Hodgkin Lymphoma Therapeutics Market Size by Application
7 China
7.1 China Non-Hodgkin Lymphoma Therapeutics Market Size (2013-2018)
7.2 Non-Hodgkin Lymphoma Therapeutics Key Players in China
7.3 China Non-Hodgkin Lymphoma Therapeutics Market Size by Type
7.4 China Non-Hodgkin Lymphoma Therapeutics Market Size by Application
8 Japan
8.1 Japan Non-Hodgkin Lymphoma Therapeutics Market Size (2013-2018)
8.2 Non-Hodgkin Lymphoma Therapeutics Key Players in Japan
8.3 Japan Non-Hodgkin Lymphoma Therapeutics Market Size by Type
8.4 Japan Non-Hodgkin Lymphoma Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Non-Hodgkin Lymphoma Therapeutics Market Size (2013-2018)
9.2 Non-Hodgkin Lymphoma Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Non-Hodgkin Lymphoma Therapeutics Market Size by Type
9.4 Southeast Asia Non-Hodgkin Lymphoma Therapeutics Market Size by Application
10 India
10.1 India Non-Hodgkin Lymphoma Therapeutics Market Size (2013-2018)
10.2 Non-Hodgkin Lymphoma Therapeutics Key Players in India
10.3 India Non-Hodgkin Lymphoma Therapeutics Market Size by Type
10.4 India Non-Hodgkin Lymphoma Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Non-Hodgkin Lymphoma Therapeutics Market Size (2013-2018)
11.2 Non-Hodgkin Lymphoma Therapeutics Key Players in Central & South America
11.3 Central & South America Non-Hodgkin Lymphoma Therapeutics Market Size by Type
11.4 Central & South America Non-Hodgkin Lymphoma Therapeutics Market Size by Application
12 International Players Profiles
12.1 Bristol Myers Squibb
12.1.1 Bristol Myers Squibb Company Details
12.1.2 Company Description and Business Overview
12.1.3 Non-Hodgkin Lymphoma Therapeutics Introduction
12.1.4 Bristol Myers Squibb Revenue in Non-Hodgkin Lymphoma Therapeutics Business (2013-2018)
12.1.5 Bristol Myers Squibb Recent Development
12.2 Celgene
12.2.1 Celgene Company Details
12.2.2 Company Description and Business Overview
12.2.3 Non-Hodgkin Lymphoma Therapeutics Introduction
12.2.4 Celgene Revenue in Non-Hodgkin Lymphoma Therapeutics Business (2013-2018)
12.2.5 Celgene Recent Development
12.3 Eli Lilly
12.3.1 Eli Lilly Company Details
12.3.2 Company Description and Business Overview
12.3.3 Non-Hodgkin Lymphoma Therapeutics Introduction
12.3.4 Eli Lilly Revenue in Non-Hodgkin Lymphoma Therapeutics Business (2013-2018)
12.3.5 Eli Lilly Recent Development
12.4 F. Hoffman La-Roche
12.4.1 F. Hoffman La-Roche Company Details
12.4.2 Company Description and Business Overview
12.4.3 Non-Hodgkin Lymphoma Therapeutics Introduction
12.4.4 F. Hoffman La-Roche Revenue in Non-Hodgkin Lymphoma Therapeutics Business (2013-2018)
12.4.5 F. Hoffman La-Roche Recent Development
12.5 GlaxoSmithKline
12.5.1 GlaxoSmithKline Company Details
12.5.2 Company Description and Business Overview
12.5.3 Non-Hodgkin Lymphoma Therapeutics Introduction
12.5.4 GlaxoSmithKline Revenue in Non-Hodgkin Lymphoma Therapeutics Business (2013-2018)
12.5.5 GlaxoSmithKline Recent Development
12.6 Accredo Health Group
12.6.1 Accredo Health Group Company Details
12.6.2 Company Description and Business Overview
12.6.3 Non-Hodgkin Lymphoma Therapeutics Introduction
12.6.4 Accredo Health Group Revenue in Non-Hodgkin Lymphoma Therapeutics Business (2013-2018)
12.6.5 Accredo Health Group Recent Development
12.7 Baxter International
12.7.1 Baxter International Company Details
12.7.2 Company Description and Business Overview
12.7.3 Non-Hodgkin Lymphoma Therapeutics Introduction
12.7.4 Baxter International Revenue in Non-Hodgkin Lymphoma Therapeutics Business (2013-2018)
12.7.5 Baxter International Recent Development
12.8 Bayer
12.8.1 Bayer Company Details
12.8.2 Company Description and Business Overview
12.8.3 Non-Hodgkin Lymphoma Therapeutics Introduction
12.8.4 Bayer Revenue in Non-Hodgkin Lymphoma Therapeutics Business (2013-2018)
12.8.5 Bayer Recent Development
12.9 Cephalon
12.9.1 Cephalon Company Details
12.9.2 Company Description and Business Overview
12.9.3 Non-Hodgkin Lymphoma Therapeutics Introduction
12.9.4 Cephalon Revenue in Non-Hodgkin Lymphoma Therapeutics Business (2013-2018)
12.9.5 Cephalon Recent Development
12.10 Eisai Pharmaceuticals
12.10.1 Eisai Pharmaceuticals Company Details
12.10.2 Company Description and Business Overview
12.10.3 Non-Hodgkin Lymphoma Therapeutics Introduction
12.10.4 Eisai Pharmaceuticals Revenue in Non-Hodgkin Lymphoma Therapeutics Business (2013-2018)
12.10.5 Eisai Pharmaceuticals Recent Development
13 Market Forecast 2018-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2018-2025)
13.10 Market Size Forecast by Application (2018-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Non-Hodgkin Lymphoma Therapeutics Key Market Segments
Table Key Players Non-Hodgkin Lymphoma Therapeutics Covered
Table Global Non-Hodgkin Lymphoma Therapeutics Market Size Growth Rate by Type 2013-2025 (Million US$)
Figure Global Non-Hodgkin Lymphoma Therapeutics Market Size Market Share by Type 2013-2025
Figure Chemotherapy Figures
Table Key Players of Chemotherapy
Figure Targeted Therapy Figures
Table Key Players of Targeted Therapy
Table Global Non-Hodgkin Lymphoma Therapeutics Market Size Growth by Application 2013-2025 (Million US$)
Figure Clinical Research Case Studies
Figure Treatment Case Studies
Figure Non-Hodgkin Lymphoma Therapeutics Report Years Considered
Table Global Non-Hodgkin Lymphoma Therapeutics Market Size 2013-2025 (Million US$)
Figure Global Non-Hodgkin Lymphoma Therapeutics Market Size and Growth Rate 2013-2025 (Million US$)
Table Global Non-Hodgkin Lymphoma Therapeutics Market Size by Regions 2013-2025 (Million US$)
Table Global Non-Hodgkin Lymphoma Therapeutics Market Size by Regions 2013-2018 (Million US$)
Table Global Non-Hodgkin Lymphoma Therapeutics Market Share by Regions 2013-2018
Figure Global Non-Hodgkin Lymphoma Therapeutics Market Share by Regions 2013-2018
Figure Global Non-Hodgkin Lymphoma Therapeutics Market Share by Regions 2018
Table Market Top Trends
Table Global Non-Hodgkin Lymphoma Therapeutics Revenue by Manufacturers (2013-2018) (Million US$)
Table Global Non-Hodgkin Lymphoma Therapeutics Market Share by Manufacturers (2013-2018)
Figure Global Non-Hodgkin Lymphoma Therapeutics Market Share by Manufacturers in 2018
Table Global Non-Hodgkin Lymphoma Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Non-Hodgkin Lymphoma Therapeutics Product/Solution/Service
Table Date of Enter into Non-Hodgkin Lymphoma Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Non-Hodgkin Lymphoma Therapeutics Market Size by Type (2013-2018) (Million US$)
Table Global Non-Hodgkin Lymphoma Therapeutics Market Size Share by Type (2013-2018)
Figure Global Non-Hodgkin Lymphoma Therapeutics Market Size Market Share by Type (2013-2018)
Table Global Non-Hodgkin Lymphoma Therapeutics Market Size by Application (2013-2018) (Million US$)
Table Global Non-Hodgkin Lymphoma Therapeutics Market Size Share by Application (2013-2018)
Figure Global Non-Hodgkin Lymphoma Therapeutics Market Size Market Share by Application (2013-2018)
Figure Global Non-Hodgkin Lymphoma Therapeutics Revenue Market Share by Application in 2017
Figure United States Non-Hodgkin Lymphoma Therapeutics Market Size 2013-2018 (Million US$)
Table United States Key Players Non-Hodgkin Lymphoma Therapeutics Revenue (2017-2018) (Million US$)
Table United States Key Players Non-Hodgkin Lymphoma Therapeutics Market Share (2017-2018)
Table United States Non-Hodgkin Lymphoma Therapeutics Market Size by Type (2013-2018) (Million US$)
Table United States Non-Hodgkin Lymphoma Therapeutics Market Share by Type (2013-2018)
Table United States Non-Hodgkin Lymphoma Therapeutics Market Size by Application (2013-2018) (Million US$)
Table United States Non-Hodgkin Lymphoma Therapeutics Market Share by Application (2013-2018)
Figure Europe Non-Hodgkin Lymphoma Therapeutics Market Size 2013-2018 (Million US$)
Table Europe Key Players Non-Hodgkin Lymphoma Therapeutics Revenue (2017-2018) (Million US$)
Table Europe Key Players Non-Hodgkin Lymphoma Therapeutics Market Share (2017-2018)
Table Europe Non-Hodgkin Lymphoma Therapeutics Market Size by Type (2013-2018) (Million US$)
Table Europe Non-Hodgkin Lymphoma Therapeutics Market Share by Type (2013-2018)
Table Europe Non-Hodgkin Lymphoma Therapeutics Market Size by Application (2013-2018) (Million US$)
Table Europe Non-Hodgkin Lymphoma Therapeutics Market Share by Application (2013-2018)
Figure China Non-Hodgkin Lymphoma Therapeutics Market Size 2013-2018 (Million US$)
Table China Key Players Non-Hodgkin Lymphoma Therapeutics Revenue (2017-2018) (Million US$)
Table China Key Players Non-Hodgkin Lymphoma Therapeutics Market Share (2017-2018)
Table China Non-Hodgkin Lymphoma Therapeutics Market Size by Type (2013-2018) (Million US$)
Table China Non-Hodgkin Lymphoma Therapeutics Market Share by Type (2013-2018)
Table China Non-Hodgkin Lymphoma Therapeutics Market Size by Application (2013-2018) (Million US$)
Table China Non-Hodgkin Lymphoma Therapeutics Market Share by Application (2013-2018)
Figure Japan Non-Hodgkin Lymphoma Therapeutics Market Size 2013-2018 (Million US$)
Table Japan Key Players Non-Hodgkin Lymphoma Therapeutics Revenue (2017-2018) (Million US$)
Table Japan Key Players Non-Hodgkin Lymphoma Therapeutics Market Share (2017-2018)
Table Japan Non-Hodgkin Lymphoma Therapeutics Market Size by Type (2013-2018) (Million US$)
Table Japan Non-Hodgkin Lymphoma Therapeutics Market Share by Type (2013-2018)
Table Japan Non-Hodgkin Lymphoma Therapeutics Market Size by Application (2013-2018) (Million US$)
Table Japan Non-Hodgkin Lymphoma Therapeutics Market Share by Application (2013-2018)
Figure Southeast Asia Non-Hodgkin Lymphoma Therapeutics Market Size 2013-2018 (Million US$)
Table Southeast Asia Key Players Non-Hodgkin Lymphoma Therapeutics Revenue (2017-2018) (Million US$)
Table Southeast Asia Key Players Non-Hodgkin Lymphoma Therapeutics Market Share (2017-2018)
Table Southeast Asia Non-Hodgkin Lymphoma Therapeutics Market Size by Type (2013-2018) (Million US$)
Table Southeast Asia Non-Hodgkin Lymphoma Therapeutics Market Share by Type (2013-2018)
Table Southeast Asia Non-Hodgkin Lymphoma Therapeutics Market Size by Application (2013-2018) (Million US$)
Table Southeast Asia Non-Hodgkin Lymphoma Therapeutics Market Share by Application (2013-2018)
Figure India Non-Hodgkin Lymphoma Therapeutics Market Size 2013-2018 (Million US$)
Table India Key Players Non-Hodgkin Lymphoma Therapeutics Revenue (2017-2018) (Million US$)
Table India Key Players Non-Hodgkin Lymphoma Therapeutics Market Share (2017-2018)
Table India Non-Hodgkin Lymphoma Therapeutics Market Size by Type (2013-2018) (Million US$)
Table India Non-Hodgkin Lymphoma Therapeutics Market Share by Type (2013-2018)
Table India Non-Hodgkin Lymphoma Therapeutics Market Size by Application (2013-2018) (Million US$)
Table India Non-Hodgkin Lymphoma Therapeutics Market Share by Application (2013-2018)
Figure Central & South America Non-Hodgkin Lymphoma Therapeutics Market Size 2013-2018 (Million US$)
Table Central & South America Key Players Non-Hodgkin Lymphoma Therapeutics Revenue (2017-2018) (Million US$)
Table Central & South America Key Players Non-Hodgkin Lymphoma Therapeutics Market Share (2017-2018)
Table Central & South America Non-Hodgkin Lymphoma Therapeutics Market Size by Type (2013-2018) (Million US$)
Table Central & South America Non-Hodgkin Lymphoma Therapeutics Market Share by Type (2013-2018)
Table Central & South America Non-Hodgkin Lymphoma Therapeutics Market Size by Application (2013-2018) (Million US$)
Table Central & South America Non-Hodgkin Lymphoma Therapeutics Market Share by Application (2013-2018)
Table Bristol Myers Squibb Company Details
Table Bristol Myers Squibb Revenue in Non-Hodgkin Lymphoma Therapeutics Business (2013-2018) (Million US$)
Figure Bristol Myers Squibb Revenue Growth Rate in Non-Hodgkin Lymphoma Therapeutics Business (2013-2018)
Table Bristol Myers Squibb Recent Development
Table Celgene Company Details
Table Celgene Revenue in Non-Hodgkin Lymphoma Therapeutics Business (2013-2018)(Million US$)
Figure Celgene Revenue Growth Rate in Non-Hodgkin Lymphoma Therapeutics Business (2013-2018)
Table Celgene Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Non-Hodgkin Lymphoma Therapeutics Business (2013-2018)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Non-Hodgkin Lymphoma Therapeutics Business (2013-2018)
Table Eli Lilly Recent Development
Table F. Hoffman La-Roche Company Details
Table F. Hoffman La-Roche Revenue in Non-Hodgkin Lymphoma Therapeutics Business (2013-2018)(Million US$)
Figure F. Hoffman La-Roche Revenue Growth Rate in Non-Hodgkin Lymphoma Therapeutics Business (2013-2018)
Table F. Hoffman La-Roche Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Non-Hodgkin Lymphoma Therapeutics Business (2013-2018)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Non-Hodgkin Lymphoma Therapeutics Business (2013-2018)
Table GlaxoSmithKline Recent Development
Table Accredo Health Group Company Details
Table Accredo Health Group Revenue in Non-Hodgkin Lymphoma Therapeutics Business (2013-2018)(Million US$)
Figure Accredo Health Group Revenue Growth Rate in Non-Hodgkin Lymphoma Therapeutics Business (2013-2018)
Table Accredo Health Group Recent Development
Table Baxter International Company Details
Table Baxter International Revenue in Non-Hodgkin Lymphoma Therapeutics Business (2013-2018)(Million US$)
Figure Baxter International Revenue Growth Rate in Non-Hodgkin Lymphoma Therapeutics Business (2013-2018)
Table Baxter International Recent Development
Table Bayer Company Details
Table Bayer Revenue in Non-Hodgkin Lymphoma Therapeutics Business (2013-2018)(Million US$)
Figure Bayer Revenue Growth Rate in Non-Hodgkin Lymphoma Therapeutics Business (2013-2018)
Table Bayer Recent Development
Table Cephalon Company Details
Table Cephalon Revenue in Non-Hodgkin Lymphoma Therapeutics Business (2013-2018)(Million US$)
Figure Cephalon Revenue Growth Rate in Non-Hodgkin Lymphoma Therapeutics Business (2013-2018)
Table Cephalon Recent Development
Table Eisai Pharmaceuticals Company Details
Table Eisai Pharmaceuticals Revenue in Non-Hodgkin Lymphoma Therapeutics Business (2013-2018)(Million US$)
Figure Eisai Pharmaceuticals Revenue Growth Rate in Non-Hodgkin Lymphoma Therapeutics Business (2013-2018)
Table Eisai Pharmaceuticals Recent Development
Table Global Non-Hodgkin Lymphoma Therapeutics Market Size by Regions (Million US$) 2018-2025
Figure Global Non-Hodgkin Lymphoma Therapeutics Market Size Share by Regions (2018-2025)
Figure Global Non-Hodgkin Lymphoma Therapeutics Market Size Share by Regions in 2025
Figure United States Non-Hodgkin Lymphoma Therapeutics Market Size Forecast (2018-2025)(Million USD)
Figure Europe Non-Hodgkin Lymphoma Therapeutics Market Size Forecast (2018-2025)(Million USD)
Figure China Non-Hodgkin Lymphoma Therapeutics Market Size Forecast (2018-2025)(Million USD)
Figure Japan Non-Hodgkin Lymphoma Therapeutics Market Size Forecast (2018-2025)(Million USD)
Figure Southeast Asia Non-Hodgkin Lymphoma Therapeutics Market Size Forecast (2018-2025)(Million USD)
Figure India Non-Hodgkin Lymphoma Therapeutics Market Size Forecast (2018-2025)(Million USD)
Figure Central & South America Non-Hodgkin Lymphoma Therapeutics Market Size Forecast (2018-2025)(Million USD)
Table Global Non-Hodgkin Lymphoma Therapeutics Market Size by Product (2018-2025) (Million US$)
Figure Global Non-Hodgkin Lymphoma Therapeutics Market Size by Product (2018-2025)
Figure Global Non-Hodgkin Lymphoma Therapeutics Market Size by Product in 2025
Table Global Non-Hodgkin Lymphoma Therapeutics Market Size by Application (2018-2025) (Million US$)
Figure Global Non-Hodgkin Lymphoma Therapeutics Market Size by Application (2018-2025)
Figure Global Non-Hodgkin Lymphoma Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
